Parkway Corporate Limited (PWN) AI Stock Analysis

• Market Cap: €27.67M
• Dividend Yield: N/A
• Average Volume (3M): 1.05M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.04
• Revenue Growth: 217.39%
• EPS Growth: 50.00%
• Country: AU
• Employees: N/A
• Sector: Industrials
• Sector Strength: 94
• Industry: Industrial Materials
• EPS (TTM): 0.00
• Shares Outstanding: 2,767,113,800
• 10 Day Avg. Volume: 524,651
• 30 Day Avg. Volume: 1,048,754
• PEG Ratio: -1.67
• Price to Book (P/B): 1.99
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 23.43
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 52 Neutral
• Price Target: AU$0.00 ▼(-100.00%Downside)

Parkway Corporate Limited's stock score is primarily impacted by its financial performance, which shows growth but lacks profitability. The technical analysis indicates a bearish trend, and the valuation is weak due to negative earnings. These factors collectively result in a moderate overall stock score.

Parkway Corporate Limited Business Overview & Revenue Model

Company Description

Parkway Corporate Limited (PWN) is a diversified conglomerate operating in the sectors of technology, finance, and healthcare. The company offers a wide range of products and services, including software solutions, financial advisory, and healthcare management systems. With a commitment to innovation and customer satisfaction, Parkway Corporate Limited leverages its expertise to deliver cutting-edge solutions to clients worldwide.

How the Company Makes Money

Parkway Corporate Limited generates revenue through multiple streams, primarily from the sale of its software solutions and healthcare management systems. The technology division earns income by providing software as a service (SaaS) to businesses, which includes subscription fees and licensing. In the finance sector, the company makes money by offering financial advisory services and portfolio management, charging clients based on assets under management and consulting fees. The healthcare segment contributes to revenue through the sale and maintenance of healthcare management systems, as well as through partnerships with healthcare providers for integrated solutions. Strategic partnerships with other firms and institutions also play a significant role in enhancing Parkway's market reach and profitability.

Parkway Corporate Limited Financial Statement Overview

Summary

Parkway Corporate Limited shows promising growth in revenue and improved cash flow management, but profitability remains a significant concern. The company's balance sheet is moderately leveraged, which, coupled with negative net income and low returns on equity, suggests ongoing financial challenges. While recent improvements in margins and cash flow are positive, sustained profitability and operational efficiency will be critical for future stability and growth.

Income Statement

The company has shown a significant revenue increase recently, with a surge from approximately 4.25 million to 8.90 million AUD year-over-year. However, the gross profit margin remains inconsistent, improving from negative figures to a positive margin of 27.26% in the latest period. Despite revenue growth, the net profit margin is still negative, indicating ongoing challenges in managing costs effectively. EBIT and EBITDA margins also reflect these operational challenges, though there is a noticeable improvement in EBITDA to 1.2% from negative figures.

Balance Sheet

Parkway Corporate Limited's balance sheet shows a high level of leverage, with a debt-to-equity ratio of 0.51, indicating moderate reliance on debt financing. The equity ratio of 57.57% suggests a stable equity base relative to total assets. However, the return on equity remains negative at -4.74%, pointing to difficulties in generating shareholder returns. The company's total assets have increased significantly, reflecting potential asset growth or acquisitions.

Cash Flow

The company has demonstrated a positive shift in free cash flow from negative figures to a positive 470,827 AUD. Additionally, the operating cash flow to net income ratio is favorable, indicating effective cash generation from operations despite net losses. The free cash flow to net income ratio is also positive, suggesting improved cash flow management. However, past fluctuations in cash flow metrics indicate potential instability in cash generation.

Breakdown	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	8.90M	4.25M	3.38M	327.30K	29.45K
Gross Profit	2.43M	-789.45K	-1.19M	-1.06M	16.71K
EBITDA	107.19K	-1.23M	-2.04M	-856.03K	-1.87M
Net Income	-734.41K	-1.68M	-2.33M	-923.72K	-2.42M
Balance Sheet
Total Assets	26.92M	11.96M	12.67M	12.97M	6.55M
Cash, Cash Equivalents and Short-Term Investments	3.49M	2.00M	4.00M	7.45M	2.00M
Total Debt	7.91M	2.80M	1.22M	494.99K	0.00
Total Liabilities	11.42M	3.80M	2.98M	1.10M	403.02K
Stockholders Equity	15.49M	8.17M	9.69M	11.87M	6.15M
Cash Flow
Free Cash Flow	470.83K	-1.74M	-3.43M	-2.73M	-1.51M
Operating Cash Flow	644.44K	-1.34M	-2.12M	-2.45M	-1.49M
Investing Cash Flow	-3.78M	-435.18K	-1.34M	1.33M	257.10K
Financing Cash Flow	4.62M	-227.25K	12.87K	6.57M	3.11M

Parkway Corporate Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.01
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:PWN, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.29 is Neutral, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:PWN.

Parkway Corporate Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	59 Neutral	AU$1.66B	10.31	11.24%	3.62%	7.22%	3.34%
AMN	54 Neutral	€36.27M	―	-88.41%	―	―	-1476.60%
PWN	52 Neutral	€27.67M	―	-4.11%	―	217.39%	50.00%
RVT	52 Neutral	AU$15.99M	―	-4.29%	―	―	10.42%
AZL	45 Neutral	AU$43.04M	―	-0.56%	―	―	96.00%
WAK	43 Neutral	AU$27.93M	―	-139.33%	―	65.38%	-46.00%
AW1	25 Underperform	AU$36.71M	―	-995.99%	―	―	4.46%

Parkway Corporate Limited Corporate Events

Parkway Corporate Limited Issues Unquoted Performance Rights

Parkway Corporate Limited has announced the issuance of 16,800,940 unquoted performance rights securities, effective May 14, 2025. This move is part of previously announced transactions and is not intended for quotation on the ASX, potentially impacting the company’s equity structure and stakeholder interests.